pirfenidone has been researched along with nadp in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Misra, HP; Rabideau, C | 1 |
| Chu, Y; Liu, E; Ma, X; Qin, W; Yin, Z; Zhang, S; Zhang, Y | 1 |
2 other study(ies) available for pirfenidone and nadp
| Article | Year |
|---|---|
Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals.
Topics: Animals; Free Radical Scavengers; Humans; Hydroxyl Radical; In Vitro Techniques; Lipid Peroxidation; Microsomes, Liver; NADP; Pyridones; Reactive Oxygen Species; Sheep | 2000 |
Pirfenidone Inhibits Hypoxic Pulmonary Hypertension through the NADPH/ROS/p38 Pathway in Adventitial Fibroblasts in the Pulmonary Artery.
Topics: Blotting, Western; Cell Line; Cell Movement; Humans; Hypertension, Pulmonary; NADP; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pulmonary Artery; Pyridones; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2020 |